United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 4, 2026 · Filed Aug 5, 2026

On Aug 4, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$517.09 for US$4.91M under a trading plan, leaving 324,443 shares. Filed Aug 5, 2026 (Form 4).

Sold
9,500 shares
Price
US$517.09 average (US$512.49 to US$520.49)
Value
US$4.91M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 4, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 4, 2026Common StockSale178US$512.49333,765Indirect
Aug 4, 2026Common StockSale182US$513.39333,583Indirect
Aug 4, 2026Common StockSale675US$514.43332,908Indirect
Aug 4, 2026Common StockSale605US$515.50332,303Indirect
Aug 4, 2026Common StockSale2,456US$516.59329,847Indirect
Aug 4, 2026Common StockSale3,142US$517.50326,705Indirect
Aug 4, 2026Common StockSale1,446US$518.40325,259Indirect
Aug 4, 2026Common StockSale517US$519.50324,742Indirect
Aug 4, 2026Common StockSale299US$520.49324,443Indirect

Source

View original at SEC

Related